Figure 1.

A flow diagram of patient care. This figure illustrates the care pathway of patients who presented for care in this study. Of the 77 transgender (TG) men, 31 (40.3%) were partners of cisgender patients undergoing treatment. The remaining 46 (59.7%) TG men underwent fertility preservation and/or family-building counseling, with 16 (20.8%) patients proceeding to fertility treatment. Of those who underwent treatment, 11 (68.8%) had a history of gender-affirming hormone therapy (GAHT) with exogenous testosterone use. Of these 11 patients, fertility treatment types included in vitro fertilization (IVF), co-IVF, embryo cryopreservation, oocyte cryopreservation, and intrauterine insemination (IUI). Cohort 1 included patients undergoing IVF, co-IVF, and embryo cryopreservation (n = 4); cohort 2 included patients undergoing oocyte cryopreservation (n = 4); and cohort 3 included patients undergoing IUI (n = 3).